Malaysia Kidney Function Test Market, By Type (Urine Tests, Blood Tests), By Component (Dipsticks, Reagents, Kits & Assays, and Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, and Others), By Region, Competition, Forecast and Opportunities 2028
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationMalaysia Kidney Function Test Market, By Type (Urine Tests, Blood Tests), By Component (Dipsticks, Reagents, Kits & Assays, and Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, and Others), By Region, Competition, Forecast and Opportunities 2028
Malaysia kidney function test market is anticipated to grow significantly in the projected period of 2024-2028. The increasing prevalence of chronic kidney diseases in Malaysia is one of the key factors driving the growth of the Malaysia kidney function test market. Chronic kidney diseases are a common health problem in Malaysia, among the adult population. The rising incidence of chronic kidney diseases has increased the demand for kidney function tests in the country. Another factor driving the market growth is the increasing awareness among the Malaysian population about the importance of early detection and management of kidney diseases. The primary cause of tuberculosis, which is most frequently caused by respiratory infections, is the type of bacteria. When an infected person cough, sneeze, or spit, it spreads via the air. It is possible to prevent and treat tuberculosis. A person if infected but not yet ill cannot spread the disease. Antibiotics are typically used to treat TB disease, which can be lethal if left untreated. The government and private healthcare organizations are taking initiatives to promote the early detection and management of chronic kidney diseases, which is further boosting the demand for kidney function tests.
According to the National Health and Morbidity Survey 2019 (NHMS 2019), 49% of Malaysians with diabetes had never undergone testing or received a diagnosis.
Rising Prevalence of Kidney Disorders is Booming the Malaysia Kidney Function Test Market
According to the Department of Statistics Malaysia (DoSM),
Download Free Sample ReportRising Technological Advancements Leads to Rising Demand for Kidney Function Test.
According to the International Trade Administration, The Ministry of Health (MOH) has received $7.7 billion from the government for operating and development costs.
According to a study published in the Journal of the American Medical Association (JAMA), the incidence of chronic kidney disease (CKD) in Malaysia is approximately 8.8%, which is higher than the global average of 7.2%.
Recent Development
- In October 2019, SiemensHealthineers launched a partnership with Healthy.io. This partnership lets the patients testtheir urine using smartphones by scanning a dipstick and therefore sending itto the doctors for further examination. The second-most common diagnostictest worldwide is urine testing. Patients with chronic renal illness mustundergo routine testing to evaluate their kidney function and look for anyindications of diabetes.
Market Segmentation
Malaysia kidney function test market is segmented based on
Company Profiles
Siemens Healthcare Private Limited, Pfizer Inc, Abbott Laboratories, Inc, Danaher Corporation, bioMérieux Malaysia Sdn Bhd, and Astrazeneca Sdn. Bhd. are some of the key players of Malaysia kidney function test market.
| Attribute | Details |
| Base Year | 2022 |
| Historic Data | 2018 – 2021 |
| Estimated Year | 2023 |
| Forecast Period | 2024 – 2028 |
| Quantitative Units | Revenue in USD Million, Volume in tons and CAGR for 2018-2022 and 2023-2028 |
| Report coverage | Revenue forecast, volume forecasting, Company shares, competitive landscape, growth factors, and trends |
| Segments covered | Type Component End User |
| Country scope | The East Malaysia and The West Malaysia |
| Key companies profiled | Siemens Healthcare Private Limited, Pfizer Inc, Abbott Laboratories, Inc, Danaher Corporation, bioMérieux Malaysia Sdn Bhd, Astrazeneca Sdn. Bhd. |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy